Prospan

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

Hedera helix, Quantity: 26 mg (Equivalent: Hedera helix, Qty 163 mg; Equivalent: emetine, Qty 0 mg)

Disponible desde:

SFI Australasia

Designación común internacional (DCI):

Hedera helix

formulario farmacéutico:

Lozenge

Composición:

Excipient Ingredients: citric acid; purified water; maltitol; medium chain triglycerides; sorbitol solution (70 per cent) (non-crystallising); Acacia; acesulfame potassium; Flavour

Vía de administración:

Oral

indicaciones terapéuticas:

Anti-inflammatory/relieve inflammation ; Decrease/reduce/relieve mild bronchial irritation ; Decrease/reduce/relieve bronchial mucous congestion ; Soothe/calm the chest ; Decrease/reduce excess chest phlegm ; Loosen chest phlegm ; Decrease/reduce excess mucous ; Decrease/reduce/relieve mild upper respiratory tract congestion ; Expectorant/clear respiratory tract mucous ; Loosen respiratory tract mucous ; Decrease/reduce/relieve mild bronchial cough ; Decrease/reduce/relieve cough ; Enhance/improve/promote/increase cough productivity ; Soothe respiratory tract mucous membranes/mucous tissue

Resumen del producto:

Visual Identification: ;

Estado de Autorización:

Licence status A

Fecha de autorización:

2017-07-24